These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 729633

  • 1. Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons.
    Di Giulio AM, Groppetti A, Cattabeni F, Galli CL, Maggi A, Algeri S, Ponzio F.
    Eur J Pharmacol; 1978 Nov 15; 52(2):201-7. PubMed ID: 729633
    [Abstract] [Full Text] [Related]

  • 2. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ.
    Br J Pharmacol; 1994 Dec 15; 113(4):1391-9. PubMed ID: 7889297
    [Abstract] [Full Text] [Related]

  • 3. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH, Spaan SJ.
    J Neurochem; 1982 Mar 15; 38(3):680-6. PubMed ID: 7057187
    [Abstract] [Full Text] [Related]

  • 4. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1988 Feb 15; 50(2):346-55. PubMed ID: 2447237
    [Abstract] [Full Text] [Related]

  • 5. Some factors affecting striatal 3-methoxytyramine concentrations in the mouse and rat.
    McQuade PS, Richard JW, Thakur M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Feb 15; 9(5-6):725-9. PubMed ID: 4089199
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F, Achilli G, Perego C, Algeri S.
    Neurosci Lett; 1981 Nov 18; 27(1):61-7. PubMed ID: 7329624
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr 18; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 8. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH, Murrin LC, Walters JR.
    Eur J Pharmacol; 1976 Mar 18; 36(1):163-71. PubMed ID: 177297
    [Abstract] [Full Text] [Related]

  • 9. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
    Mignot E, Laude D.
    J Neurochem; 1985 Nov 18; 45(5):1527-33. PubMed ID: 2864397
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 12. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
    Heal DJ, Frankland AT, Buckett WR.
    Neuropharmacology; 1990 Dec 18; 29(12):1141-50. PubMed ID: 2293058
    [Abstract] [Full Text] [Related]

  • 13. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct 18; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

  • 14. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr 18; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 15. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A, Baranyi M, Windisch K, Petkova-Kirova P, Gagov H, Kalfin R.
    Brain Res Bull; 2017 Sep 18; 134():246-252. PubMed ID: 28802898
    [Abstract] [Full Text] [Related]

  • 16. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C, Scheel-Krüger J.
    Eur J Pharmacol; 1976 Aug 18; 38(2):305-12. PubMed ID: 986308
    [Abstract] [Full Text] [Related]

  • 17. 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo.
    Kehr W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun 18; 293(3):209-15. PubMed ID: 958511
    [Abstract] [Full Text] [Related]

  • 18. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG, Hattox SE, Roth RH.
    Eur J Pharmacol; 1979 Jun 15; 56(3):225-36. PubMed ID: 477719
    [Abstract] [Full Text] [Related]

  • 19. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
    Brown EE, Damsma G, Cumming P, Fibiger HC.
    J Neurochem; 1991 Aug 15; 57(2):701-7. PubMed ID: 1906527
    [Abstract] [Full Text] [Related]

  • 20. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S, Watanabe A, Takahashi R.
    Eur J Pharmacol; 1986 Apr 16; 123(2):287-94. PubMed ID: 3086109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.